- Akebia and
Otsuka, partners in Vafseo’s U.S. marketing and sales, are seeking the court’s declaration that the patents shouldn’t have been issued and that vadadustat, the active ingredient in Vafseo, doesn’t infringe any valid claims of the patents, according to complaintfiled Monday in federal court in Wilmington, Delaware
- An application for approval of vadadustat was
submittedby Akebia to the U.S. ...
March 30, 2021, 2:44 PM